About Globela Pharma
Globela Pharma is a Healthcare company based in Surat (India) founded in 1996. Finished formulations like tablets, capsules, syrups, and injectables are manufactured. The company has 150 employees. Globela Pharma was last valued at $51.09 million in January 2022. Its chief executive, as recorded, is Bhanu Vaghashia. Its Indian entity Globela Pharma Private Limited reported revenue of ₹296 Cr. Globela Pharma offers products and services including Finished Dosage Formulations, APIs, Intermediates, and DC Granules and Pellets. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its competitors include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed competitors have raised funding.
Company details
Globela Pharma was established in 1996 in Surat, India, within the pharmaceutical sector. Various finished formulations, including tablets, capsules, syrups, and injectables, are produced across therapeutic areas such as antibiotics, analgesics, cardiovascular drugs, anticancer treatments, gastrointestinal remedies, multivitamins, and additional categories. Manufacturing operations are supported by facilities certified under ISO 9001:2015 and WHO-GMP standards.
- Headquarters Surat, India
- Employees 150
- Stage Minicorn
- SectorsHealthcare
- Website category Health · Pharmacy
- Email••••••••
- Phone•••• ••••
- Website globelapharma.com
- Social LinkedIn X Facebook Instagram
- Legal Name Globela Pharma Pvt Ltd
- Date of Incorporation 08 Feb, 2006
- Jurisdiction Surat, Gujarat, India
- Annual Revenue₹296 Cr
FY 2025 · +13% YoY
- Net Profit₹5.89 Cr
FY 2025 · 2% margin
- EBITDA₹36.85 Cr
FY 2025 · 12% margin
- Latest Funding Round$3.39M (USD), Unspecified
Jan 2022
- InvestorsSomerset Indus Capital Partners
& 7 more
- Employee Count150
Associated legal entities of Globela Pharma
Globela Pharma is associated with 2 registered companies on The Company Check; the primary company is Globela Pharma Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Globela Pharma Private Limited CIN U24230GJ2006PTC047699 | Active | 08 Feb 2006 | Surat, Gujarat | ₹296 Cr | 150 | 6 | View details |
| Globela Biotech Llp CIN AAR-6265 | Active | 16 Jan 2020 | Surat, Gujarat | 2 | View details |
Products & Services of Globela Pharma
Globela Pharma offers a comprehensive portfolio of products and services, including Finished Dosage Formulations, APIs, Intermediates, and DC Granules and Pellets.
High-quality drugs for therapeutic areas like oncology
Raw materials for drug manufacturing and innovation
Semi-finished products for pharmaceutical applications
Components for drug production and delivery systems
Funding Insights of Globela Pharma
- Total Rounds 3
- Last Round Unspecified — $3.39M
- First Round $321,164
(Mar 2011)
- Investors Count 8
All 3 funding rounds of Globela Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2022 | $3.39M | Unspecified | $51.09M | Somerset Indus Capital Partners | |
| Sep 2021 | $7.66M | Unspecified | $47.84M | Somerset Indus Capital Partners | – |
| Mar 2011 | $321,164 | Unspecified | $••••• | Rasik M Gondalia |
| Date | Valuation | Stage |
|---|---|---|
| Jan 2022 | $51.09M | •••••••• |
| Sep 2021 | $47.84M | •••••••• |
Last known valuation $51.09M (Jan 2022). 8 investors in total: 1 institutional and 7 angel.
Investors in Globela Pharma
Globela Pharma has secured backing from 8 investors, including venture fund and angel investors. Prominent investors backing the company include Somerset Indus Capital Partners, Karthic Jayaraman and Firoze Jehangir Irani.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare investments focused on accessibility, affordability, and ESG integration in India. | 2011 | somersetinduscap.com | Mumbai, India | |
KJ Karthic Jayaraman | Angel investor and tech entrepreneur, co-founder of WayCool Foods, focused on agritech. | unknown_9c62cacde01e4565b | ||
FJ Firoze Jehangir Irani | unknown_40eedba4131c454cb | |||
RM Rasik M Gondalia | unknown_1f2e783a9a7f46ee9 | |||
BV Biren V Gondaliya | unknown_56e62619625544ab9 | |||
MT Madhuri Thiridhi | unknown_59f32ff5e9af4feda | |||
UA Uaday Alaparthi | unknown_ad0b77f769e24387b | |||
RB Ranjana Bhargav | unknown_621f5cc7fdda4f03b |
Investor details for Globela Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Globela Pharma Private Limited (Globela Pharma)
Globela Pharma Private Limited is the primary company behind Globela Pharma. The boards of the 2 registered companies of Globela Pharma currently have 6 directors; the longest-serving is Bhanubhai Shambhubhai Vaghashia, appointed in 2006. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Bhanubhai Shambhubhai Vaghashia DIN 01627823 | Managing Director | 08 Feb 2006 | 20 yrs 9 mo | Globela Pharma Private Limited |
| Urmilaben Bhanubhai Vaghasiya DIN 03308074 | Director | 25 Oct 2010 | 16 yrs | Globela Pharma Private Limited |
| Ripple Jayantbhai Rama DIN 08661924 | Designated Partner | 16 Jan 2020 | 6 yrs 9 mo | Globela Biotech Llp |
| Priyank Vaghashia DIN 08662062 | Designated Partner | 16 Jan 2020 | 6 yrs 9 mo | Globela Biotech Llp, Globela Pharma Private Limited |
| Mayur Anand Sirdesai DIN 02830863 | Director | 23 Sep 2021 | 5 yrs 1 mo | Globela Pharma Private Limited |
| Pietro Ermanno Stefanutti DIN 09465896 | Director | 13 Jan 2022 | 4 yrs 9 mo | Globela Pharma Private Limited |
People of Globela Pharma
2 people are tracked at Globela Pharma (1 in leadership, 1 in team); the tracked headcount is 150.
| Name | Role | Group |
|---|---|---|
Bhanu Vaghashia | CEO & MD | Leadership |
Disha Patel | Quality Assurance Executive | Team |
Complete people profiles for Globela Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Globela Pharma
Figures of Globela Pharma Private Limited, the primary company behind Globela Pharma, for FY 2025. Revenue was ₹296 Cr (+13% year on year). Net profit was ₹5.89 Cr (2% margin). EBITDA was ₹36.85 Cr (12% margin). Revenue has grown at a compounded annual rate of +22% over three years and +27% over five years.
- ₹296 CrRevenue · FY 2025 · +13% YoY
- ₹5.89 CrNet profit · 2% margin
- ₹36.85 CrEBITDA · 12% margin
- ₹56.92 CrPaid-up capital
- 150Employees (provident fund records)
- +22%Revenue CAGR, 3 years
- +27%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Globela Pharma Private Limited are on its company page.
Detailed financial statements for Globela Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Globela Pharma
4 dated milestones of Globela Pharma across 26 years, from founding to its latest funding, stage changes and deals.
- Founded Globela Pharma is founded.
- Funding First funding round of $321K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Unspecified, of $3.4M.
Competitors of Globela Pharma
Globela Pharma has 3 listed competitors in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed competitors of Globela Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Globela Pharma
The website of Globela Pharma (globelapharma.com) receives about 5.6K visits a month and ranks #2,737,199 among all websites worldwide, #3,450 in Pharmacy.
- Monthly visits5.6K
▼ 35.6% vs previous month
- Unique visitors4.1K
per month
- Global rank#2,737,199
among all websites
- Category rank#3,450
Health · Pharmacy
- Bounce rate70%
- Pages per visit1.3
- Average visit14 sec
- DevicesDesktop 16% · Mobile 84%
Websites whose visitors overlap most with Globela Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| lazzpharma.com | 100% | 83.8K | #503,231 | View details | |
orionpharmabd.com | orionpharmabd.com | 97% | #5,442,532 | – | |
| pharmaceuticals.gov.in | 93% | View details | |||
| pharmabiz.com | 93% | #665,634 | View details | ||
actizapharma.com | actizapharma.com | 80% | #934,598 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for Globela Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Globela Pharma (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Globela Pharma
Complete news archive for Globela Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Globela Pharma
Globela Pharma was founded in 1996 and raised its 1st funding round 15 years after it was founded.
Globela Pharma is headquartered in Surat, India. It is registered at Surat, Gujarat, India.
Bhanu Vaghashia is the CEO of Globela Pharma, as recorded in our data.
Globela Pharma has 150 employees.
The primary company behind Globela Pharma, Globela Pharma Private Limited, reported revenue of ₹296 Cr for FY 2025, up 13% year on year.
Globela Pharma was established in 1996 in Surat, India, within the pharmaceutical sector. Various finished formulations, including tablets, capsules, syrups, and injectables, are produced across therapeutic areas such as antibiotics, analgesics, cardiovascular drugs, anticancer treatments, gastrointestinal remedies, multivitamins, and additional categories. Manufacturing operations are supported by facilities certified under ISO 9001:2015 and WHO-GMP standards.
Globela Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Globela Pharma offers Finished Dosage Formulations, APIs, Intermediates, and DC Granules and Pellets.
Globela Pharma has 8 investors. Key investors include Somerset Indus Capital Partners, Karthic Jayaraman, Firoze Jehangir Irani, Rasik M Gondalia, and Biren V Gondaliya.
The valuation of Globela Pharma is $51.09M as of Jan 2022.
Globela Pharma is associated with 2 legal entities: Globela Pharma Private Limited, Globela Biotech Llp.
The legal entities of Globela Pharma currently have 7 directors, including Ripple Jayantbhai Rama, Priyank Vaghashia, Tony Girishkumar Gandhi and others.